The Dual Burden of Automated Insulin Delivery

Artificial pancreas systems, also known as automated insulin delivery (AID) systems, represent a profound shift in the management of type 1 diabetes. By integrating a continuous glucose monitor (CGM), an insulin pump, and advanced control algorithms, these systems effectively mimic the regulatory function of a healthy pancreas. Patients and clinicians have celebrated the improvements in time-in-range, reduced hypoglycemic events, and the psychological relief from constant manual decision-making.

Yet, for a significant percentage of users, this technological freedom comes with a persistent physical cost. The dermatological burden of wearing multiple medical devices continuously—sensors replaced every 7 to 14 days and infusion sets changed every 2 to 3 days—can be severe. Research indicates that 25% to 40% of CGM and insulin pump users report clinically significant skin reactions. These range from mild erythema and itching to painful blisters, hyperpigmentation, and scarring. When comfort is compromised, the temptation to take a "device holiday" grows, often resulting in deteriorating glycemic control. addressing this skin-device interface is not merely a matter of comfort; it is an essential component of successful long-term therapy.

How Artificial Pancreas Systems Function

To understand the skin challenges, it is necessary to understand the physical and chemical demands of the technology. A closed-loop system relies on three core components working in harmony:

  • Continuous Glucose Monitor (CGM): A small sensor inserted into the subcutaneous tissue, typically on the abdomen, arm, or upper gluteal area. It measures interstitial glucose levels and transmits data wirelessly.
  • Insulin Pump: A wearable device that delivers rapid-acting insulin through a cannula inserted under the skin.
  • Algorithm: Software housed in the pump, a smartphone, or both. It analyzes CGM readings and automatically adjusts basal insulin delivery to keep glucose levels in a target range.

Commercial systems like the Tandem t:slim X2 with Control-IQ, Medtronic 780G, and the Omnipod 5 have gained widespread adoption. Open-source systems like AndroidAPS and Loop offer similar functionality for those with compatible hardware. Regardless of the platform, every system demands a reliable, long-term anchor to the body. The adhesive patch or tape is the critical interface that bears this load. It must maintain adhesion for days, resist sweat and water exposure, and then remove cleanly. Achieving all these requirements with a single material is a formidable bioengineering challenge.

The Scale of the Dermatological Challenge

Skin irritation stems from two distinct mechanisms: irritant contact dermatitis and allergic contact dermatitis. Distinguishing between them is critical for treatment.

Irritant Contact Dermatitis (ICD)

ICD is the most common reaction and results from physical trauma to the skin barrier. The repetitive cycle of applying an occlusive patch, leaving it in place for an extended period, and then stripping it off disrupts the stratum corneum. Moisture accumulates under the adhesive, leading to maceration. This creates a red, itchy, or stinging rash that is confined strictly to the area of the patch. Most users will experience some form of ICD over the course of their therapy.

Allergic Contact Dermatitis (ACD)

ACD is an immune-mediated reaction to a specific chemical component in the device. The most well-known culprit is isobornyl acrylate (IBOA), a sensitizing chemical used in the production of certain medical adhesives and plastics. A study published in Contact Dermatitis identified IBOA as a primary allergen in many CGM sensors, leading to severe, spreading, and weeping eczema in susceptible individuals. Other potential allergens include colophony (rosin), epoxy resins, and various methacrylates. ACD presents as an intensely itchy, vesicular rash that often extends beyond the boundaries of the patch.

Consequences for Glycemic Control

The dermatological burden directly undermines therapy adherence. When a site becomes painful or unsightly, users may delay placing a new device, stretch wear time beyond recommended limits, or abandon specific areas of the body. This leads to overuse of remaining sites, poor sensor accuracy, and increased risk of infusion set failure. The psychological component cannot be ignored; constant skin pain and disfigurement contribute to diabetes burnout and reduced quality of life.

"For patients with severe adhesive allergies, the choice is often between optimal glycemic control and having intact, healthy skin. We need manufacturers to prioritize skin health as a primary design parameter, not an afterthought."

— Dr. Emily Larson, Dermatologist specializing in medical device reactions

Building a Resilient Skin Barrier: A Practical Protocol

Managing skin health requires a systematic, proactive approach. A consistent care routine can dramatically reduce irritation and extend comfortable device wear.

Pre-Application: Preparing the Canvas

Proper skin preparation sets the stage for adhesion and health.

  • Clean: Wash the site with a mild, fragrance-free, antibacterial soap. Rinse thoroughly and pat dry. Residual soap can interfere with adhesion.
  • Dry: Allow the skin to air dry completely. Any moisture trapped under the adhesive accelerates maceration.
  • Barrier Prep: Use a skin barrier film or wipe. Products containing n-butyl acrylate (a common film-former) create a protective layer between the skin and the device adhesive. Be cautious with barrier prep if you have known allergies to acrylates. A patch test is often recommended. Let the barrier film dry to a tacky finish before applying the device.
  • Hair: For areas with significant hair, clipping (not shaving) the hair with an electric trimmer improves adhesion and reduces pain upon removal. Shaving creates micro-cuts and increases the risk of infection.

Optimizing Placement and Rotation

Repeated placement in the exact same spot is a fast track to scar tissue and lipohypertrophy.

  • Rotation Mapping: Develop a systematic site rotation schedule. Use a smartphone app or a physical chart to track locations. For example, move clockwise around the abdomen or alternate between left and right arm for sensors.
  • Avoid Problem Areas: Steer clear of waistbands, belt lines, scar tissue, stretch marks, and areas where the skin folds or creases.
  • Leverage the "Belt Loop" Rule: A good rule of thumb is to imagine drawing a circle around the navel two inches out and avoiding that central zone. This ensures placement over muscle or adipose tissue with consistent interstitial fluid.

Overpatches and Advanced Anchoring

For users requiring extra adhesion security (athletes, swimmers, or those with heavy sweating), overpatches are valuable tools. However, they can increase occlusion and irritation if not used carefully.

  • Hydrocolloid Barriers: Cut a hydrocolloid patch to size and place it under the sensor or pump. The sensor filament penetrates the hydrocolloid, while the hydrocolloid protects the skin from the harsh adhesive. This works best with sensors that have a flexible or removable transmitter.
  • Medical Silk or Paper Tape: Use pre-cut medical tape frames over the device edges. These are gentler than standard overpatch adhesives and easier to remove.
  • Specialized Overpatches: Products from vendors like Skin Grip, GriffGrips, or ExpressionMed use medical-grade adhesives designed to hold up to moisture. When removing them, always use an adhesive remover wipe to gently lift the edges rather than pulling on the skin.

The Art of Removal

Aggressive removal is a primary cause of irritation. Ripping a device off damages the stratum corneum and triggers inflammation.

  • Use Adhesive Removers: Saturate an adhesive remover wipe or cotton ball with a medical-grade remover (e.g., Uni Solve or Goo Gone Medical). Hold it against the edge of the adhesive for 30-60 seconds. The solvent will dissolve the bond.
  • Stretch, Don't Pull: Gently roll or stretch the adhesive horizontally away from the insertion site, keeping the remover in contact with the advancing edge. This prevents the "tenting" effect that pulls on the skin.
  • Clean Residue: Use a fresh remover wipe or a gentle oil-based cleanser (like coconut or jojoba oil, if tolerated) to dissolve any remaining adhesive residue. Avoid harsh rubbing with alcohol, which is drying and irritating.

Troubleshooting Severe Reactions

If standard barrier techniques fail and you are experiencing significant blistering, weeping, or a rapidly spreading rash, medical intervention is required.

  • Patch Testing: A dermatologist can perform patch testing to identify the specific allergen (IBOA, colophony, etc.). This allows users to avoid specific brands or components.
  • Prescription Topicals: In many cases, a prescribed topical corticosteroid or calcineurin inhibitor (like Tacrolimus) can calm the immune response. A common protocol involves spraying Fluticasone propionate on the skin and letting it dry before applying the barrier wipe and the device.
  • Alternative Devices: For confirmed IBOA allergy, switching to a device known to be IBOA-free (like the Dexcom G7 or certain Libre models) is the most effective long-term solution.

Technological Innovations in Device Design

The device industry is acutely aware of the dermatological burden and is investing in smarter materials and designs.

Smaller, Low-Profile Sensors

The Dexcom G7 and the Abbott FreeStyle Libre 3 feature significantly smaller profiles and reduced adhesive footprints compared to their predecessors. A smaller patch means less occlusive surface area, lower total exposure to adhesives, and reduced friction risk. The Omnipod 5, while still a tubeless patch pump, has a rounded, flexible housing that moves with the body better than rigid rectangular designs.

Biocompatible and Silicone Adhesives

Leading medical adhesive manufacturers, such as 3M, are developing high-performance silicone-based adhesives. Silicone adhesives are inherently less reactive than acrylate-based ones. They form a secure bond but are gentle to remove and leave minimal residue. The trade-off is often cost and initial adhesion strength, but the dermatological benefits are substantial. We are beginning to see these silicone adhesives adopted in next-generation sensor applicators.

Hydrogel Interfaces

Hydrogel patches are being explored as an interface layer. Hydrogels are high-water-content materials that can be infused with soothing agents. They provide a cushioning layer between the device and the skin, reducing friction and allowing the skin to breathe. This technology is still emerging for AID systems but shows promise for reducing maceration.

The Implantable Alternative: Eversense

The Eversense E3 CGM offers a unique solution to the dermatological problem: it bypasses the outer skin entirely. The sensor is a small cylinder implanted entirely under the skin in a quick office procedure. The transmitter is held on the surface by a thin, temporary adhesive patch. Users report dramatically less skin irritation because the body is not reacting to a foreign sensor filament protruding through the skin barrier. This option is particularly valuable for patients with severe adhesive allergies who cannot tolerate traditional CGMs.

Special Considerations for Specific Populations

Skin physiology and lifestyle factors vary widely. Tailoring the approach to the individual is key.

Children and Toddlers

Dermatological challenges are often amplified in younger children. Their skin is thinner, has a faster turnover rate, and is more permeable. They are also more prone to getting sensors soaked during bath time or ripped off during play.

  • Parental Best Practices: Use a waterproof barrier film specifically designed for children. Consider using a medical-grade silicone tape over the device edges for an extra layer of protection. Involve the child in choosing fun, colorful overpatches to build a positive association with the device.
  • Cannula Insertion: For toddlers with little subcutaneous fat, insertion angles and depth are critical. Use shorter cannulas (6mm or 4mm) and avoid bony areas like the back of the arm. The upper gluteal area often provides the best combination of adhesion and comfort for very young children.

Athletes and Active Adults

Sweat is the enemy of medical adhesives. The saline nature of sweat undermines the chemical bond of the adhesive, leading to premature failure and increased friction.

  • Pre-Workout Prep: Clean the site with an alcohol wipe to remove oils and sweat residue before applying a fresh device or overpatch. Apply a skin barrier primer that is specifically designed for high-moisture environments.
  • Antiperspirant for Skin: A surprising but effective tip is to apply a thin layer of non-irritating, solid antiperspirant to the skin around (but not under) the device site. This reduces localized sweating without exposing the sensor to liquid.
  • Overpatch Selection: Use a waterproof, sweat-resistant overpatch from a reputable vendor. Change overpatches more frequently than the sensor if they become saturated.

The Elderly Population

Geriatric skin is fragile, thinner, and heals more slowly. The risk of skin tears and pressure injuries is higher.

  • Gentle Adhesives Only: Avoid acrylic-based adhesives if possible. Look for silicone or gentle medical tape. Apply a thick, liquid barrier film to prevent the adhesive from bonding too aggressively to the fragile epidermis.
  • Frequent Inspection: Check the site daily for early signs of breakdown, such as persistent redness or blanching. Do not delay site changes if the skin shows signs of maceration.
  • Moisturize: Between device applications, aggressively moisturize the skin with a thick, fragrance-free emollient (like CeraVe cream or Vanicream) to help the skin barrier recover.

Future Directions: Toward a Seamless Interface

The next generation of AID systems is being designed from the ground up with the skin interface as a primary constraint.

  • Smart Adhesives: Researchers are engineering adhesives that are responsive to pH or temperature. These "smart" adhesives could be strong while on the dry skin but have chemically triggered debonding mechanisms to allow for painless removal without solvents.
  • Anti-Inflammatory Drug-Eluting Patches: Some trials are investigating patches that slowly release a low-dose anti-inflammatory agent (like a corticosteroid or an antihistamine) directly to the skin interface to suppress irritation at the source.
  • Microneedle Arrays: Future CGM sensors may use microneedle arrays that penetrate the skin painlessly and are held in place by micro-mechanical interlocking rather than chemical adhesion. This would eliminate the need for large adhesive patches entirely.
  • Standardized Biocompatibility Regulations: There is growing pressure on regulatory bodies to require more rigorous dermatological testing for Class III wearable medical devices. This would force the supply chain to adopt materials that are known to be non-sensitizing, potentially reducing the prevalence of ACD across the patient population.

Conclusion: Comfort as a Clinical Endpoint

The artificial pancreas is a triumph of biomedical engineering, but its potential is only fully realized when the physical interface is invisible and comfortable. Skin irritation is not a minor cosmetic issue; it is a primary driver of non-adherence and a significant source of suffering for millions. Addressing it requires a team effort. Users must become experts in their own skin care and site rotation. Clinicians must ask about skin problems at every visit and be prepared to offer specific, actionable solutions beyond "try a different site." Manufacturers must continue to move beyond simple acrylate adhesives and embrace biocompatible materials, smaller form factors, and fundamentally new approaches like implantable sensors.

By elevating skin comfort to a primary clinical endpoint, the diabetes community can ensure that the liberation offered by automated insulin delivery is not restricted to those with the toughest skin. Achieving a comfortable, reliable, and long-term skin-device partnership is the next great frontier in the pursuit of a truly seamless and worry-free life with type 1 diabetes.

For further reading on managing device-related skin issues, refer to the dermatological guidelines and patient resources available through organizations like the JDRF and Beyond Type 1. For clinical studies on allergens such as IBOA, a search of the PubMed database provides an extensive review of the literature.